Esther M. Willems-Zijlstra
Amsterdam, NH 1105AZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Capsid-Targeting Biologic Achieves Broad HIV-1 Neutralization with a High Barrier to Resistance.
Journal: International journal of molecular sciences
Published: May 26, 2026
Anti-capsid nanobodies function as HIV-1 capsid inhibitors by intracellular capsid degradation.
Journal: Communications biology
Published: September 11, 2025
Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells.
Journal: The Journal of infectious diseases
Published: October 26, 2023
Transmission of Zika virus by dendritic cell subsets in skin and vaginal mucosa.
Journal: Frontiers in immunology
Published: December 16, 2022
Crosstalk between R848 and abortive HIV-1 RNA-induced signaling enhances antiviral immunity.
Journal: Journal of leukocyte biology
Published: January 04, 2022
Vaginal dysbiosis associated-bacteria Megasphaera elsdenii and Prevotella timonensis induce immune activation via dendritic cells.
Journal: Journal of reproductive immunology
Published: August 15, 2019
Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
Journal: Frontiers in immunology
Published: August 02, 2019
Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection.
Journal: Scientific reports
Published: January 16, 2018
Erratum: HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.
Journal: Nature immunology
Published: March 22, 2017
HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.
Journal: Nature immunology
Published: July 21, 2016
Last Updated: 09/26/2026